HNCSX
Price
$19.13
Change
-$0.15 (-0.78%)
Updated
Feb 21 closing price
Net Assets
321.06M
RERBX
Price
$54.18
Change
-$0.50 (-0.91%)
Updated
Feb 21 closing price
Net Assets
131.04B
Ad is loading...

HNCSX vs RERBX

Header iconHNCSX vs RERBX Comparison
Open Charts HNCSX vs RERBXBanner chart's image
Hartford International Growth R4
Price$19.13
Change-$0.15 (-0.78%)
VolumeN/A
Net Assets321.06M
American Funds Europacific Growth R2
Price$54.18
Change-$0.50 (-0.91%)
VolumeN/A
Net Assets131.04B
HNCSX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HNCSX vs. RERBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNCSX is a Buy and RERBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 131B vs. HNCSX (321M). RERBX pays higher dividends than HNCSX: RERBX (1.00) vs HNCSX (0.43). HNCSX was incepted earlier than RERBX: HNCSX (18 years) vs RERBX (23 years). RERBX is a more actively managed with annual turnover of: 34.00 vs. HNCSX (20.00). HNCSX has a lower initial minimum investment than RERBX: HNCSX (0) vs RERBX (250). HNCSX annual gain was more profitable for investors over the last year : 10.79 vs. RERBX (0.62). HNCSX return over 5 years is better than : 22.69 vs. RERBX (4.32).
HNCSXRERBXHNCSX / RERBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years23 years-
Gain YTD8.7556.549134%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets321M131B0%
Annual Yield % from dividends0.431.0043%
Returns for 1 year10.790.621,746%
Returns for 3 years13.60-0.32-4,302%
Returns for 5 years22.694.32525%
Returns for 10 years48.0015.57308%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KFS7.66-0.01
-0.13%
Kingsway Financial Services
ENLV1.00-0.02
-1.81%
Enlivex Therapeutics Ltd
PGRE4.52-0.10
-2.16%
Paramount Group
PTC161.65-4.11
-2.48%
PTC
RNA31.12-1.41
-4.33%
Avidity Biosciences